Anthracimycin
Not to be confused with anthramycin.
Clinical data | |
---|---|
ATC code | none |
Identifiers | |
ChemSpider | 29272409 |
Chemical and physical data | |
Formula | C25H32O4 |
Molar mass | 396.519 g/mol |
3D model (Jmol) | Interactive image |
| |
|
Anthracimycin is a polyketide antibiotic discovered in 2013. Anthracimycin is derived from marine actinobacteria. In preliminary laboratory research, it has shown activity against Bacillus anthracis,[1] the bacteria that causes anthrax, and against methicillin-resistant Staphylococcus aureus (MRSA).[2]
References
- ↑ Jang, Hwa Jang; Nam, S.-J.; Locke, J. B.; Kauffman, C. A.; Beatty, D. S.; Paul, L. A.; Fenical, W. (2013). "Anthracimycin, a potent anthrax antibiotic from a marine-derived actinomycete.". Angewandte Chemie International Edition. 52 (30): 7822–7824. doi:10.1002/anie.201302749.
- ↑ "Anthracimycin: New Antibiotic Kills Anthrax, MRSA". Sci-News.com. Sci-News.com. Retrieved 21 July 2013.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.